Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/9484373
Conclusion of this study
None was serious. Because of its high efficacy, excellent tolerability, and low cost, riboflavin is an interesting option for migraine prophylaxis and a candidate for a comparative trial with an established prophylactic drug.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
